Clinical studies have demonstrated that patients using GLP-1 medications experience weight reductions of 10-15%, which translates into improved airway patency, reduced snoring, and better sleep quality
Each phase has its own timeline, which can be affected by age, nutrition, and overall health
(2018) published thorough research in Current Pharmaceutical Design showing BPC-157 accelerated healing of gastric ulcers by 60% compared to controls within 14 days
Cardiogen CJC-1295 Cortagen Crystagen Cerebrolysina Cartalax D
As weight loss and diabetes drugs like Ozempic, Wegovy and Mounjaro increase in popularity, more users are learning about the risk of potentially serious gastrointestinal side effects associated with the medications, and are choosing to cut back on their dosages without consulting their doctors
Here are more details from the episode (audio version / Apple Subscriber version): Current and potential uses for Ozempic and GLP-1 (6:42 / 4:01) Common side effects from Ozempic (8:48 / 6:07) Understanding the obesity and chronic disease crisis (9:33 / 6:52) Long-term risks associated with Ozempic (14:47 / 12:06) Combatting the idea that obesity is genetic (17:54 / 15:13) Can you be healthy at any size
